Balaram Ghosh

46PUBLICATIONS
43CO-AUTHORS
Cellular nervous systemPharmacogenomicsCheminformatics and quantitative structure-activity relationshipsMolecular targetsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 20, 2026
Design to neuroprotection: a blood brain barrier permeable selective HDAC3 inhibitor active against chemical and viral insults.

|Jul 16, 2026
RP-HPLC quantification and separation of isomeric bacosides and exploration of their anti-schizophrenic potential by network pharmacology.

|May 11, 2026
A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: in silico design, synthesis, biological assessment and binding interaction analysis.

|Jan 07, 2026
Unlocking the therapeutic potential of HDAC8-degrading PROTACs: progress, challenges, and future directions.

Suvankar Banerjee, Nilanjan Adhikari, Balaram Ghosh

|Jan 05, 2026
Molecular Frameworks for ERK1/2 Inhibition: Lessons from Synthetic and SAR Explorations.

Venkatesh Muthukumar, Anushka Vashishth, Subashani Maniam

|Oct 29, 2025
PROTAC-Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies.

Ambati Himaja, Debojyoti Halder, Suvankar Banerjee

Pageof 8

Frequent Collaborators

19 joint publications

Nilanjan Adhikari

16 joint publications

Tarun Jha

14 joint publications

Suvankar Banerjee

12 joint publications

Swati Biswas